Andy B Lassman

23PUBLICATIONS
149CO-AUTHORS
Biological adaptationCellular nervous systemMining, energy and natural resources lawMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Feb 03, 2026
Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Aug 08, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

|Apr 30, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update.

Jaishri Blakeley, Nimish A Mohile, Hans Messersmith

|Apr 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Clinical Insights.

Nimish A Mohile, Andrew B Lassman, David Schiff

Pageof 4

Frequent Collaborators

7 joint publications

Martin van den Bent

6 joint publications

David Schiff

4 joint publications

Jaishri Blakeley

4 joint publications

Mei-Yin C Polley